These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35085262)

  • 21. Sleep Characteristics and Cerebrospinal Fluid Progranulin in Older Adults: The CABLE Study.
    Wang M; Sun FR; Bi YL; Ma YH; Yin JJ; Shen XN; Wang XT; Tan L; Yu JT
    Neurotox Res; 2021 Jun; 39(3):764-773. PubMed ID: 33443646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progranulin in neurodegenerative dementia.
    Wang XM; Zeng P; Fang YY; Zhang T; Tian Q
    J Neurochem; 2021 Jul; 158(2):119-137. PubMed ID: 33930186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations.
    Pickering-Brown SM; Rollinson S; Du Plessis D; Morrison KE; Varma A; Richardson AM; Neary D; Snowden JS; Mann DM
    Brain; 2008 Mar; 131(Pt 3):721-31. PubMed ID: 18192287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of Lysosomal Proteins Progranulin and Prosaposin Associated with Increased Neurofibrillary Tangle Development in Alzheimer Disease.
    Mendsaikhan A; Tooyama I; Serrano GE; Beach TG; Walker DG
    J Neuropathol Exp Neurol; 2021 Sep; 80(8):741-753. PubMed ID: 34374777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Common variant in GRN is a genetic risk factor for hippocampal sclerosis in the elderly.
    Dickson DW; Baker M; Rademakers R
    Neurodegener Dis; 2010; 7(1-3):170-4. PubMed ID: 20197700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progranulin deficiency induces overactivation of WNT5A expression via TNF-α/NF-κB pathway in peripheral cells from frontotemporal dementia-linked granulin mutation carriers.
    Alquézar C; de la Encarnación A; Moreno F; López de Munain A; Martín-Requero Á
    J Psychiatry Neurosci; 2016 Jun; 41(4):225-39. PubMed ID: 26624524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progranulin as a therapeutic target for dementia.
    Galimberti D; Fenoglio C; Scarpini E
    Expert Opin Ther Targets; 2018 Jul; 22(7):579-585. PubMed ID: 29889573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prosaposin is a regulator of progranulin levels and oligomerization.
    Nicholson AM; Finch NA; Almeida M; Perkerson RB; van Blitterswijk M; Wojtas A; Cenik B; Rotondo S; Inskeep V; Almasy L; Dyer T; Peralta J; Jun G; Wood AR; Frayling TM; Fuchsberger C; Fowler S; Teslovich TM; Manning AK; Kumar S; Curran J; Lehman D; Abecasis G; Duggirala R; Pottier C; Zahir HA; Crook JE; Karydas A; Mitic L; Sun Y; Dickson DW; Bu G; Herz J; Yu G; Miller BL; Ferguson S; Petersen RC; Graff-Radford N; Blangero J; Rademakers R
    Nat Commun; 2016 Jun; 7():11992. PubMed ID: 27356620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroinflammation modulates the association of PGRN with cerebral amyloid-β burden.
    Xu W; Tan CC; Cao XP; Tan L;
    Neurobiol Aging; 2021 Jul; 103():52-59. PubMed ID: 33813350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C-->T (Arg493X) mutation: an international initiative.
    Rademakers R; Baker M; Gass J; Adamson J; Huey ED; Momeni P; Spina S; Coppola G; Karydas AM; Stewart H; Johnson N; Hsiung GY; Kelley B; Kuntz K; Steinbart E; Wood EM; Yu CE; Josephs K; Sorenson E; Womack KB; Weintraub S; Pickering-Brown SM; Schofield PR; Brooks WS; Van Deerlin VM; Snowden J; Clark CM; Kertesz A; Boylan K; Ghetti B; Neary D; Schellenberg GD; Beach TG; Mesulam M; Mann D; Grafman J; Mackenzie IR; Feldman H; Bird T; Petersen R; Knopman D; Boeve B; Geschwind DH; Miller B; Wszolek Z; Lippa C; Bigio EH; Dickson D; Graff-Radford N; Hutton M
    Lancet Neurol; 2007 Oct; 6(10):857-68. PubMed ID: 17826340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementia.
    Holler CJ; Taylor G; McEachin ZT; Deng Q; Watkins WJ; Hudson K; Easley CA; Hu WT; Hales CM; Rossoll W; Bassell GJ; Kukar T
    Mol Neurodegener; 2016 Jun; 11(1):46. PubMed ID: 27341800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of progranulin polymorphism rs5848 with neurodegenerative diseases: a meta-analysis.
    Chen Y; Li S; Su L; Sheng J; Lv W; Chen G; Xu Z
    J Neurol; 2015; 262(4):814-22. PubMed ID: 25578179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline.
    Suárez-Calvet M; Capell A; Araque Caballero MÁ; Morenas-Rodríguez E; Fellerer K; Franzmeier N; Kleinberger G; Eren E; Deming Y; Piccio L; Karch CM; Cruchaga C; Paumier K; Bateman RJ; Fagan AM; Morris JC; Levin J; Danek A; Jucker M; Masters CL; Rossor MN; Ringman JM; Shaw LM; Trojanowski JQ; Weiner M; Ewers M; Haass C; ;
    EMBO Mol Med; 2018 Dec; 10(12):. PubMed ID: 30482868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of lysosomal proteins Progranulin and Prosaposin and their interactions in Alzheimer's disease and aged brains: increased levels correlate with neuropathology.
    Mendsaikhan A; Tooyama I; Bellier JP; Serrano GE; Sue LI; Lue LF; Beach TG; Walker DG
    Acta Neuropathol Commun; 2019 Dec; 7(1):215. PubMed ID: 31864418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GRN 3'UTR+78 C>T is not associated with risk for Parkinson's disease.
    Jasinska-Myga B; Wider C; Opala G; Krygowska-Wajs A; Barcikowska M; Czyzewski K; Baker M; Rademakers R; Uitti RJ; Farrer MJ; Ross OA; Wszolek ZK
    Eur J Neurol; 2009 Aug; 16(8):909-11. PubMed ID: 19473366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Putative risk alleles for LATE-NC with hippocampal sclerosis in population-representative autopsy cohorts.
    Hokkanen SRK; Kero M; Kaivola K; Hunter S; Keage HAD; Kiviharju A; Raunio A; Tienari PJ; Paetau A; Matthews FE; Fleming J; Graff C; Polvikoski TM; Myllykangas L; Brayne C;
    Brain Pathol; 2020 Mar; 30(2):364-372. PubMed ID: 31376286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration.
    Goossens J; Bjerke M; Van Mossevelde S; Van den Bossche T; Goeman J; De Vil B; Sieben A; Martin JJ; Cras P; De Deyn PP; Van Broeckhoven C; van der Zee J; Engelborghs S
    Alzheimers Res Ther; 2018 Mar; 10(1):31. PubMed ID: 29559004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebrospinal fluid biomarkers in Progranulin mutations carriers.
    Carecchio M; Fenoglio C; Cortini F; Comi C; Benussi L; Ghidoni R; Borroni B; De Riz M; Serpente M; Cantoni C; Franceschi M; Albertini V; Monaco F; Rainero I; Binetti G; Padovani A; Bresolin N; Scarpini E; Galimberti D
    J Alzheimers Dis; 2011; 27(4):781-90. PubMed ID: 21891865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progranulin and Amyloid-β Levels: Relationship to Neuropsychology in Frontotemporal and Alzheimer's Disease.
    Körtvélyessy P; Gukasjan A; Sweeney-Reed CM; Heinze HJ; Thurner L; Bittner DM
    J Alzheimers Dis; 2015; 46(2):375-80. PubMed ID: 25777512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia.
    Rademakers R; Eriksen JL; Baker M; Robinson T; Ahmed Z; Lincoln SJ; Finch N; Rutherford NJ; Crook RJ; Josephs KA; Boeve BF; Knopman DS; Petersen RC; Parisi JE; Caselli RJ; Wszolek ZK; Uitti RJ; Feldman H; Hutton ML; Mackenzie IR; Graff-Radford NR; Dickson DW
    Hum Mol Genet; 2008 Dec; 17(23):3631-42. PubMed ID: 18723524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.